Swiss-based Altium acquires major stake in PHI
Phase Holographic Imaging (PHI) announces that Altium S.A. recently acquired Formue Nord’s entire holdings in PHI of 2 416 679 shares and 1 491 362 TO 3 warrants and committed to exercise the obtained warrants.The acquired holdings correspond to 11,8 % of the total number of shares and votes in PHI. Altium had no holdings in PHI before this transaction. Altium CEO, Goran Dubravcic, notes: “PHI and Altium share the same vision that regenerative medicine will transform healthcare and cure presently incurable diseases. In this transformation of medicine, we see PHI’s non-invasive cell